Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Apr 26;11(5):ofae234.
doi: 10.1093/ofid/ofae234. eCollection 2024 May.

Coronary Microvascular Dysfunction Is Present Among Well-Treated Asymptomatic Persons With HIV and Similar to Those With Diabetes

Affiliations
Clinical Trial

Coronary Microvascular Dysfunction Is Present Among Well-Treated Asymptomatic Persons With HIV and Similar to Those With Diabetes

Suman Srinivasa et al. Open Forum Infect Dis. .

Abstract

Background: Coronary microvascular dysfunction (CMD) could be a potential underlying mechanism for myocardial disease in HIV.

Methods: Comparisons of coronary flow reserve corrected for heart rate-blood pressure product (CFRCOR) were made among people with HIV (PWH) with no known history of cardiovascular disease (CVD) or diabetes mellitus, persons without HIV (PWOH), and persons with diabetes (PWDM) and no known history of CVD or HIV.

Results: PWH (n = 39, 74% male, age 55 [7] years, body mass index [BMI] 32.3 (26.8-34.9) kg/m2, duration of antiretroviral therapy 13 [5] years, CD4+ count 754 [598-961] cells/μL) were similar to PWOH (n = 69, 74% male, age 55 [8] years, BMI 32.2[25.6-36.5] kg/m2) and PWDM (n = 63, 63% male, age 55 [8] years, BMI 31.5 [28.6-35.6] kg/m2). CFRCOR was different among groups: PWOH 2.76 (2.37-3.36), PWH 2.47 (1.92-2.93), and PWDM 2.31 (1.98-2.84); overall P = .003. CFRCOR was reduced comparing PWH to PWOH (P = .04) and PWDM to PWOH (P = .007) but did not differ when comparing PWH to PWDM (P = .98). A total 31% of PWH had CFRCOR < 2.0, a critical cutoff for CMD, compared to 14% of PWOH and 27% with PWDM. A total 40% of women with HIV had a CFRCOR < 2.0 compared to 6% of women without HIV (P = .02).

Conclusions: Subclinical CMD is present among chronically infected and well-treated, asymptomatic PWH who are immunologically controlled. This study demonstrates CFR is reduced in PWH compared to PWOH and comparable to PWDM, further highlighting that well-treated HIV infection is a CVD-risk enhancing factor for CMD similar to diabetes. Clinical Trials Registration: NCT02740179.

Keywords: HIV; coronary flow reserve; myocardial blood flow; myocardial dysfunction.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. S. S. was the recipient of a Gilead Sciences Research Scholars award. S K. G. has received research funding from KOWA, Gilead, ViiV, and Theratechnologies, received consulting fees from Theratechnologies and ViiV, and is a member of the Scientific Advisory Board of Marathon Asset Management. All disclosures are unrelated to this manuscript. All other authors report no potential conflicts.

Figures

Figure 1.
Figure 1.
Coronary microvascular dysfunction among persons with HIV. Global CFR corrected for heart rate-blood pressure product (CFRCOR) as assessed on coronary PET among persons without HIV/DM, persons with HIV, and persons with DM. Box plot represents the 25th and 75th percentile and line within the box represents the median. Dots represent data for each participant. Overall group comparison was made using the Kruskal-Wallis Test. Paired comparisons are made using Tukey-Kramer. *P < .05.

References

    1. Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation 2018; 138:1100–12. - PMC - PubMed
    1. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506–12. - PMC - PubMed
    1. Galazka PDC, Marcelo F. Cardiac PET/CT and prognosis. Cardiovasc Innov Appl 2017; 2:47–59.
    1. Ziadi MC, Dekemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011; 58:740–8. - PubMed
    1. Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011; 124:2215–24. - PMC - PubMed

Publication types

Associated data